Nom du produit:2,2'-(5-((4H-1,2,4-Triazol-4-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile)

IUPAC Name:2-[3-(1-cyano-1-methylethyl)-5-[(4H-1,2,4-triazol-4-yl)methyl]phenyl]-2-methylpropanenitrile

CAS:120511-92-4
Formule moléculaire:C17H19N5
Pureté:97%
Numéro de catalogue:CM488712
Poids moléculaire:293.37

Unité d'emballage Stock disponible Prix($) Quantité
CM488712-100mg in stock Ʌȁ
CM488712-250mg in stock ưNJȬ
CM488712-1g 1-2 Weeks NJƀư

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:120511-92-4
Formule moléculaire:C17H19N5
Point de fusion:-
Code SMILES:CC(C1=CC(CN2C=NN=C2)=CC(C(C)(C)C#N)=C1)(C)C#N
Densité:
Numéro de catalogue:CM488712
Poids moléculaire:293.37
Point d'ébullition:
N° Mdl:MFCD19105534
Stockage:Sealed in dry,Room Temperature

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products